Syneos Health, Inc. (SYNH) Tops Q4 EPS by 5c, Offers Guidance

Syneos Health, Inc. (NASDAQ: SYNH) reported Q4 EPS of $1.48, $0.05 better than the analyst estimate of $1.43. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.41 billion.

GUIDANCE:

Syneos Health, Inc. sees FY2022 EPS of $4.98-$5.24, versus the consensus of $5.11. Syneos Health, Inc. sees FY2022 revenue of $5.6-5.75 billion, versus the consensus of $5.71 billion.

For earnings history and earnings-related data on Syneos Health, Inc. (SYNH) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c